ONLINE DATABASE SEARCH -
OI-LS-381-MEMO
1.
61500 OI-LS-381;
SCIFINDER-OI-8/13/2007
Thuggacins, macrolide antibiotics active against Mycobacterium
tuberculosis: isolation from myxobacteria, structure elucidation, conformation
analysis and biosynthesis
Steinmetz, Heinrich, Irschik, Herbert, Kunze, Brigitte, Reichenbach,
Hans, Hoefle, Gerhard, and Jansen, Rolf
Chem.--Eur. J.
2007. 13(20):
5822-5832
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
61501 OI-LS-381;
SCIFINDER-OI-8/13/2007
Enhanced killing of intracellular multidrug-resistant Mycobacterium
tuberculosis by compounds that affect the activity of efflux
pumps
Amaral, Leonard, Martins, Marta, and Viveiros,
Miguel
J. Antimicrob. Chemother. 2007. 59(6): 1237-1246
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
61502 OI-LS-381;
WOS-OI-8/10/2007
Synthesis of Putative Chain Terminators of Mycobacterial Arabinan
Biosynthesis
Smellie, I. et al.
Organic & Biomolecular Chemistry 2007. 5(14): 2257-2266
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247768900023
4.
61503 OI-LS-381;
SCIFINDER-OI-8/13/2007
Efficacy of clarithromycin on Mycobacterium avium which proliferates in
bronchial epithelial cells
Yamazaki, Yoshitaka
Jpn. J. Antibiot. 2007.
60(Suppl. A): 28-31
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
61504 OI-LS-381;
WOS-OI-8/10/2007
New Anti-Tuberculosis Therapies
Portero, J. and Rubio, M.
Expert Opinion on Therapeutic Patents 2007. 17(6): 617-637
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247719900003
6.
61505 OI-LS-381;
SCIFINDER-OI-8/13/2007
IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to
Mycobacterium avium infection and influences efficacy of antibiotic
therapy
Roque Susana, Nobrega Claudia, Appelberg Rui, and Correia-Neves
Margarida
J Immunol 2007.
178(12): 8028-35.
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
61506 OI-LS-381;
SCIFINDER-OI-8/13/2007
Invasion and Egress by the obligate intracellular parasite Toxoplasma
gondii: potential targets for the development of new antiparasitic
drugs
Lavine, MD and Arrizabalaga, G
Curr. Pharm. Des. 2007.
13(6): 641-651
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
61507 OI-LS-381;
SCIFINDER-OI-8/13/2007
Coordination to copper(II) strongly enhances the in vitro antimicrobial
activity of pyridine-derived N(4)-tolyl thiosemicarbazones
Mendes, Isolda C, Moreira, Juliana P, Mangrich, Antonio S, Balena,
Solange P, Rodrigues, Bernardo L, and Beraldo, Heloisa
Polyhedron 2007.
26(13): 3263-3270
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
61508 OI-LS-381;
SCIFINDER-OI-8/13/2007
Antioxidant, antimalarial and antimicrobial activities of tannin-rich
fractions, ellagitannins and phenolic acids from Punica granatum
L
Reddy, Muntha K, Gupta, Sashi K, Jacob, Melissa R, Khan, Shabana I, and
Ferreira, Daneel
Planta Med. 2007.
73(5): 461-467
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
61509 OI-LS-381;
SCIFINDER-OI-8/13/2007
Triple therapy of initial high-dose interferon with ribavirin and
amantadine for patients with chronic hepatitis C
Uyama, Hirokazu, Nakamura, Hideji, Hayashi, Eijiro, Ogawa, Hiroyuki,
Enomoto, Hirayuki, Yoshida, Kenya, Okuda, Yorihide, Yamamoto, Mitsunari, Hada,
Toshikazu, and Hayashi, Norio
Hepatol. Res. 2007.
37(5): 325-330
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
61510 OI-LS-381;
SCIFINDER-OI-8/13/2007
Preparation of azacytosine acyclic nucleotide derivatives useful as
antiviral agents
Holy, Antonin, Krecmerova, Marcela, Piskala, Alois, Andrei, Graciela,
Snoeck, Robert, De Clercq, Erik, Neyts, Johan, and Naesens,
Lieve
PATENT: WO
2007065231 ISSUE DATE: 20070614
APPLICATION: 2006 PP:
96pp.
ASSIGNEE: (K.U. Leuven
Research & Development, Belg. and Institute of Organic Chemistry and
Biochemistry of Academy of Sciences of the Czech
Republic)
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
61511 OI-LS-381;
SCIFINDER-OI-8/13/2007
Mechanism of drug-resistance in human cytomegalovirus
Eizuru Yoshito
Nippon Rinsho 2007.
65 Suppl 2 Pt. 1: 476-9.
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
61512 OI-LS-381;
SCIFINDER-OI-8/13/2007
Antivirals for herpesviruses and cytomegalovirus
Minematsu Toshio
Nippon Rinsho 2007.
65 Suppl 2 Pt. 1: 396-400.
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
61513 OI-LS-381;
SCIFINDER-OI-8/13/2007
Structural characterization and antifungal studies of some mixed ligand
schiff base complexes with 6-bromo-2-thio 3-phenyl quinazoline-4(3H) one
thiosemicarbazone
Rai, BK, Choudhary, Pramod, Rana, Sweta, and Sahi,
Poonam
Orient. J. Chem. 2007.
23(1): 271-275
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
61514 OI-LS-381;
WOS-OI-8/17/2007
Therapeutic Efficacy of Posaconazole Against Isolates of Candida Albicans
With Different Susceptibilities to Fluconazole in a Vaginal
Model
Gonzalez, G. et al.
Medical Mycology 2007.
45(3): 221-224
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247374400004
16.
61515 OI-LS-381;
WOS-OI-8/17/2007
Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus
Polymerase Inhibitors
Pauwels, F. et al.
Journal of Virology 2007.
81(13): 6909-6919
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247404900014
17.
61516 OI-LS-381;
SCIFINDER-OI-8/13/2007
Synthesis and antimicrobial activity of some novel
2-(4-substituted-phenyl)-5- (naphthalen-1-yloxy-methyl) [1,3,4] oxadiazoles and
1-[2-(4-substituted phenyl)-5-(naphthaten-1-
yloxy-methyl)-[1,3,4]oxadiazol-3-yl]-ethanones
Rajak, Harish, Kharya, Murlidhar, and Mishra,
Pradeep
Int. J. Chem. Sci. 2007.
5(1): 365-379
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
61517 OI-LS-381;
WOS-OI-8/17/2007
Synthesis of Methylene-Bridged Analogues of Biologically Active Pteridine
Derivatives
Slusarczyk, M. et al.
European Journal of Organic Chemistry 2007.(18):
2987-2994
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247799200011
19.
61518 OI-LS-381;
WOS-OI-8/17/2007
Hts, Chemical Hybridization, and Drug Design Identify a Chemically Unique
Antituberculosis Agent-Coupling Serendipity and Rational Approaches to Drug
Discovery
Mao, J. et al.
Chemmedchem 2007.
2(6): 811-813
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247392900008
20.
61519 OI-LS-381;
PUBMED-OI-8/20/2007
Characterization of the metabolic activation of a HCV nucleoside
inhibitor beta -D-2'-deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and
identification of a novel active 5'-triphosphate species
Ma, H, Jiang, WR, Robledo, N, Leveque, V, Ali, S, Lara-Jaime, T,
Masjedizadeh, M, Smith, DB, Cammack, N, Klumpp, K, and Symons,
J
J Biol Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
61520 OI-LS-381;
PUBMED-OI-8/20/2007
Synthesis and Enzyme Inhibitory Activity of the S-Nucleoside Analogue of
the Ribitylaminopyrimidine Substrate of Lumazine Synthase and Product of
Riboflavin Synthase
Talukdar, A, Illarionov, B, Bacher, A, Fischer, M, and Cushman,
M
J Org Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
22.
61521 OI-LS-381;
PUBMED-OI-8/20/2007
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and
Mycobacterium avium by Novel Dideoxy Nucleosides
Rai, D, Johar, M, Srivastav, NC, Manning, T, Agrawal, B, Kunimoto, DY,
and Kumar, R
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
23.
61522 OI-LS-381;
PUBMED-OI-8/20/2007
Identification of Inhibitors for Mycobacterial Protein Tyrosine
Phosphatase B (MptpB) by Biology-Oriented Synthesis (BIOS)
Correa, IR Jr, Noren-Muller, A, Ambrosi, HD, Jakupovic, S, Saxena, K,
Schwalbe, H, Kaiser, M, and Waldmann, H
Chem Asian J 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
24.
61523 OI-LS-381;
PUBMED-OI-8/20/2007
Design, Synthesis, and Pharmacological Evaluation of Mefloquine-Based
Ligands as Novel Antituberculosis Agents
Mao, J, Wang, Y, Wan, B, Kozikowski, AP, and Franzblau,
SG
ChemMedChem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
25.
61524 OI-LS-381;
PUBMED-OI-8/20/2007
Chemoenzymatic synthesis of feruloyl D: -arabinose as a potential
anti-mycobacterial agent
Vafiadi, C, Topakas, E, Alderwick, LJ, Besra, GS, and Christakopoulos,
P
Biotechnol Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
26.
61525 OI-LS-381;
PUBMED-OI-8/20/2007
Morphine Inhibits Intrahepatic Interferon- alpha Expression and Enhances
Complete Hepatitis C Virus Replication
Li, Y, Ye, L, Peng, JS, Wang, CQ, Luo, GX, Zhang, T, Wan, Q, and Ho,
WZ
J Infect Dis 2007.
196(5): 719-30
View Data on the NIAID Therapeutics Website
HYPERLINK:
27.
61526 OI-LS-381;
PUBMED-OI-8/20/2007
Antifungal potential of disulfiram
Khan, S, Singhal, S, Mathur, T, Upadhyay, DJ, and Rattan,
A
Nippon Ishinkin Gakkai Zasshi 2007. 48(3): 109-13
View Data on the NIAID Therapeutics Website
HYPERLINK:
28.
61527 OI-LS-381;
PUBMED-OI-8/20/2007
Identification and characterization of an aspartyl protease from
Cryptococcus neoformans
Pinti, M, Orsi, CF, Gibellini, L, Esposito, R, Cossarizza, A, Blasi, E,
Peppoloni, S, and Mussini, C
FEBS Lett 2007.
581(20): 3882-6
View Data on the NIAID Therapeutics Website
HYPERLINK:
29.
61528 OI-LS-381;
PUBMED-OI-8/20/2007
Antifungal activity of the amyrin derivatives and in vitro inhibition of
Candida albicans adhesion to human epithelial cells
Johann, S, Soldi, C, Lyon, JP, Pizzolatti, MG, and Resende,
MA
Lett Appl Microbiol 2007.
45(2): 148-53